243 related articles for article (PubMed ID: 27909059)
1. The Role of the Histone Methyltransferase Enhancer of Zeste Homolog 2 (EZH2) in the Pathobiological Mechanisms Underlying Inflammatory Bowel Disease (IBD).
Sarmento OF; Svingen PA; Xiong Y; Sun Z; Bamidele AO; Mathison AJ; Smyrk TC; Nair AA; Gonzalez MM; Sagstetter MR; Baheti S; McGovern DP; Friton JJ; Papadakis KA; Gautam G; Xavier RJ; Urrutia RA; Faubion WA
J Biol Chem; 2017 Jan; 292(2):706-722. PubMed ID: 27909059
[TBL] [Abstract][Full Text] [Related]
2. Disruption of FOXP3-EZH2 Interaction Represents a Pathobiological Mechanism in Intestinal Inflammation.
Bamidele AO; Svingen PA; Sagstetter MR; Sarmento OF; Gonzalez M; Braga Neto MB; Kugathasan S; Lomberk G; Urrutia RA; Faubion WA
Cell Mol Gastroenterol Hepatol; 2019; 7(1):55-71. PubMed ID: 30510991
[TBL] [Abstract][Full Text] [Related]
3. Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients.
Ueno A; Jijon H; Chan R; Ford K; Hirota C; Kaplan GG; Beck PL; Iacucci M; Fort Gasia M; Barkema HW; Panaccione R; Ghosh S
Inflamm Bowel Dis; 2013 Nov; 19(12):2522-34. PubMed ID: 24097227
[TBL] [Abstract][Full Text] [Related]
4. The epigenetic modification during the induction of Foxp3 with sodium butyrate.
Cao T; Zhang X; Chen D; Zhang P; Li Q; Muhammad A
Immunopharmacol Immunotoxicol; 2018 Aug; 40(4):309-318. PubMed ID: 30003817
[TBL] [Abstract][Full Text] [Related]
5. Chemokine receptor CCR7 regulates the intestinal TH1/TH17/Treg balance during Crohn's-like murine ileitis.
McNamee EN; Masterson JC; Veny M; Collins CB; Jedlicka P; Byrne FR; Ng GY; Rivera-Nieves J
J Leukoc Biol; 2015 Jun; 97(6):1011-22. PubMed ID: 25637591
[TBL] [Abstract][Full Text] [Related]
6. Mucosal Immunity Related to FOXP3
Cho J; Kim S; Yang DH; Lee J; Park KW; Go J; Hyun CL; Jee Y; Kang KS
J Korean Med Sci; 2018 Dec; 33(52):e336. PubMed ID: 30584414
[TBL] [Abstract][Full Text] [Related]
7. BMI1 maintains the Treg epigenomic landscape to prevent inflammatory bowel disease.
Gonzalez MM; Bamidele AO; Svingen PA; Sagstetter MR; Smyrk TC; Gaballa JM; Hamdan FH; Kosinsky RL; Gibbons HR; Sun Z; Ye Z; Nair A; Ramos GP; Braga Neto MB; Wixom AQ; Mathison AJ; Johnsen SA; Urrutia R; Faubion WA
J Clin Invest; 2021 Jun; 131(12):. PubMed ID: 34128475
[TBL] [Abstract][Full Text] [Related]
8. Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells.
Cook L; Stahl M; Han X; Nazli A; MacDonald KN; Wong MQ; Tsai K; Dizzell S; Jacobson K; Bressler B; Kaushic C; Vallance BA; Steiner TS; Levings MK
Gastroenterology; 2019 Dec; 157(6):1584-1598. PubMed ID: 31513797
[TBL] [Abstract][Full Text] [Related]
9. Death Receptor 3 Signaling Controls the Balance between Regulatory and Effector Lymphocytes in SAMP1/YitFc Mice with Crohn's Disease-Like Ileitis.
Li Z; Buttó LF; Buela KA; Jia LG; Lam M; Ward JD; Pizarro TT; Cominelli F
Front Immunol; 2018; 9():362. PubMed ID: 29545797
[TBL] [Abstract][Full Text] [Related]
10. Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases.
Hovhannisyan Z; Treatman J; Littman DR; Mayer L
Gastroenterology; 2011 Mar; 140(3):957-65. PubMed ID: 21147109
[TBL] [Abstract][Full Text] [Related]
11. Crossover Subsets of CD4
Li J; Ueno A; Iacucci M; Fort Gasia M; Jijon HB; Panaccione R; Kaplan GG; Beck PL; Luider J; Barkema HW; Qian J; Gui X; Ghosh S
Dig Dis Sci; 2017 Sep; 62(9):2357-2368. PubMed ID: 28573508
[TBL] [Abstract][Full Text] [Related]
12. The chromatin-modifying enzyme Ezh2 is critical for the maintenance of regulatory T cell identity after activation.
DuPage M; Chopra G; Quiros J; Rosenthal WL; Morar MM; Holohan D; Zhang R; Turka L; Marson A; Bluestone JA
Immunity; 2015 Feb; 42(2):227-238. PubMed ID: 25680271
[TBL] [Abstract][Full Text] [Related]
13. Promises and paradoxes of regulatory T cells in inflammatory bowel disease.
Lord JD
World J Gastroenterol; 2015 Oct; 21(40):11236-45. PubMed ID: 26523099
[TBL] [Abstract][Full Text] [Related]
14. T2 enhances in situ level of Foxp3+ regulatory cells and modulates inflammatory cytokines in Crohn's disease.
Li G; Ren J; Wang G; Gu G; Hu D; Ren H; Hong Z; Wu X; Liu S; Li J
Int Immunopharmacol; 2014 Feb; 18(2):244-8. PubMed ID: 24369313
[TBL] [Abstract][Full Text] [Related]
15. Increased CD4
Ma YH; Zhang J; Chen X; Xie YF; Pang YH; Liu XJ
World J Gastroenterol; 2016 Nov; 22(42):9356-9367. PubMed ID: 27895423
[TBL] [Abstract][Full Text] [Related]
16. PDCD5 negatively regulates autoimmunity by upregulating FOXP3(+) regulatory T cells and suppressing Th17 and Th1 responses.
Xiao J; Liu C; Li G; Peng S; Hu J; Qu L; Lv P; Zhang Y; Ma D; Chen Y
J Autoimmun; 2013 Dec; 47():34-44. PubMed ID: 24012345
[TBL] [Abstract][Full Text] [Related]
17. IL-1β promotes Th17 differentiation by inducing alternative splicing of FOXP3.
Mailer RK; Joly AL; Liu S; Elias S; Tegner J; Andersson J
Sci Rep; 2015 Oct; 5():14674. PubMed ID: 26441347
[TBL] [Abstract][Full Text] [Related]
18. Inflammation-induced repression of chromatin bound by the transcription factor Foxp3 in regulatory T cells.
Arvey A; van der Veeken J; Samstein RM; Feng Y; Stamatoyannopoulos JA; Rudensky AY
Nat Immunol; 2014 Jun; 15(6):580-587. PubMed ID: 24728351
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of Ezh2 methyltransferase by FOXP3: new insight of FOXP3 into chromatin remodeling?
Shen Z; Chen L; Yang X; Zhao Y; Pier E; Zhang X; Yang X; Xiong Y
Biochim Biophys Acta; 2013 Oct; 1833(10):2190-200. PubMed ID: 23688634
[TBL] [Abstract][Full Text] [Related]
20. Generation of RORγt
Kim BS; Lu H; Ichiyama K; Chen X; Zhang YB; Mistry NA; Tanaka K; Lee YH; Nurieva R; Zhang L; Yang X; Chung Y; Jin W; Chang SH; Dong C
Cell Rep; 2017 Oct; 21(1):195-207. PubMed ID: 28978473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
